{"id":387424,"date":"2020-11-24T07:03:28","date_gmt":"2020-11-24T12:03:28","guid":{"rendered":"http:\/\/www.marketnewsdesk.com\/?p=387424"},"modified":"2020-11-24T07:03:28","modified_gmt":"2020-11-24T12:03:28","slug":"orchard-therapeutics-to-present-at-piper-sandler-32nd-annual-virtual-healthcare-conference","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/orchard-therapeutics-to-present-at-piper-sandler-32nd-annual-virtual-healthcare-conference\/","title":{"rendered":"Orchard Therapeutics to Present at Piper Sandler 32nd Annual Virtual Healthcare Conference"},"content":{"rendered":"<div class=\"mw_release\">\n<p align=\"left\">BOSTON and LONDON, Nov.  24, 2020  (GLOBE NEWSWIRE) &#8212; Orchard Therapeutics (Nasdaq: ORTX), a global gene therapy leader, today announced that its chief executive officer, Bobby Gaspar, M.D., Ph.D. will participate in a pre-recorded fireside chat as part of the Piper Sandler 32nd Annual Virtual Healthcare Conference. Management will also be available for one-on-one meetings on Tuesday, December 1, 2020.<\/p>\n<p>The fireside chat is available for on-demand viewing under &#8220;Events&#8221; in the Investors &amp; Media section of the company&#8217;s website at <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=YzklCUB2RDkySwctitWb1Ou41pRYoa90Jk98SSmqm2HXbWxl0j49GqoCsOxNBrf4uQQt1AoAHF1i2YJgTtxnSeJ96XYDHHE72K_QJO1HLdM=\" rel=\"nofollow noopener noreferrer\" target=\"_blank\">www.orchard-tx.com<\/a> and will remain available for approximately 90 days.<\/p>\n<p>\n        <strong>About Orchard<\/strong>\n      <\/p>\n<p>Orchard Therapeutics is a global gene therapy leader dedicated to transforming the lives of people affected by rare diseases through the development of innovative, potentially curative gene therapies. Our <em>ex vivo<\/em> autologous gene therapy approach harnesses the power of genetically modified blood stem cells and seeks to correct the underlying cause of disease in a single administration. In 2018, Orchard acquired GSK\u2019s rare disease gene therapy portfolio, which originated from a pioneering collaboration between GSK and the San Raffaele Telethon Institute for Gene Therapy in Milan, Italy. Orchard now has one of the deepest and most advanced gene therapy product candidate pipelines in the industry spanning multiple therapeutic areas where the disease burden on children, families and caregivers is immense and current treatment options are limited or do not exist.<\/p>\n<p>Orchard has its global headquarters in London and U.S. headquarters in Boston. For more information, please visit <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=YzklCUB2RDkySwctitWb1C8MVCRIEhZJBJ7DAeCHM2CAO2yVbTarYs9_fpbILTzTYNK8EPrMr6KdlqYR4pKRbEtHimMO3QkAWvumD1ABRuk=\" rel=\"nofollow noopener noreferrer\" target=\"_blank\">www.orchard-tx.com<\/a>, and follow us on <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=fCL3hj9d1HwgSAJ5aXzK2t3LHxS3idv9UjxWbIVXhl1sDXx4Uom98lTPh0CG_TZBLVLo1XHOdXiXqKE5NVMkkg==\" rel=\"nofollow noopener noreferrer\" target=\"_blank\">Twitter<\/a> and <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=LXNr1qmtkPkFQd1lpvHb3N-R_oGV-c7413I-F-ppBQ7uE3pSl09-f7q7rQVEnuJqsG0uog4tKBB8zPxrLqj1iuBTzqimZ6NyjdaXmds_vZBfLeRXhT_bhecrHTdJNIgM\" rel=\"nofollow noopener noreferrer\" target=\"_blank\">LinkedIn<\/a>.<\/p>\n<p>\n        <strong>Availability of Other Information About Orchard<\/strong>\n      <\/p>\n<p>Investors and others should note that Orchard communicates with its investors and the public using the company website (<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=YzklCUB2RDkySwctitWb1NWKdFI-u4sg2ryzaszQ3qnwjBF5DU0GNVDkpsRA3Zwz8Dn3Mt9th2aQMsFumbb9Uzta-3NfCzw1hjbrVZYnwW75y0odzje2tCbS6cQrJuYQHL_Muy5B-8k0rqFd76oENSicp8eHCxGqNWtGx6Jyed1zIdVDSR4EH0M4tj0W4NA2Z6C5Ej_cJ0jIdHY5u9-E-G3CyEfLLz0R8rUvL2NmsS964irhzGK-8hxO5sAYHlx5\" rel=\"nofollow noopener noreferrer\" target=\"_blank\">www.orchard-tx.com<\/a>), the investor relations website (<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=xJ83P3JtYlNdPpnFuC-lCwm6PvFW_ky5y2K1Kr3kcQOxb7jGB9fsq_npFWeOmkekndO87dgAS-dy5F-wLFLxcyz7r3vZ9KSdMMOLARI1MFdaqPp5BfTglhdqZRKmxm-cQzjDKDqvoAg0jlO0ydD80M-IO3H2KTAXC3XVUDAD1kuqBx_5IAfsJBIaUyjpn9mfFqgBjGKoJh_MkdwMpIuJ1Q1ghgeWlqGqGOnRiuUggp4=\" rel=\"nofollow noopener noreferrer\" target=\"_blank\">ir.orchard-tx.com<\/a>), and on social media (<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=fCL3hj9d1HwgSAJ5aXzK2n6Lslo7_zX0yaIuLV-XE7cGPDewKs80fsaHLrbGBo7GT9rIDqqcetSPq-ld3Ut59AueujMlPA_FbE5BnjD12sBX7ifcMp9j9nsvdElwqRtCXvvRpPgLWIDcAmRDEcjMqZTsJA4wmaJvQ7Oof2xjbw7_dbGfpscuSz3igJWjFdiZxYXhC2uHtRHZimY63q8_YQ==\" rel=\"nofollow noopener noreferrer\" target=\"_blank\">Twitter<\/a>\u00a0and\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=LXNr1qmtkPkFQd1lpvHb3AFIGpSfxBqsO8P-fIap4vHufCQOpPaviydWj9Pu-IoRRTGQcWx-oEOEHAnB8AXoDt4-Fo194C3vMtm57bhnavK6OzE-zVATIMBNp2ohAx9Sg8xDC0pi4DDVFN5t6zbToq4HWbMjP0PN1ycVjFqCMeU0U02kHBBWMQu4oS_RaiKk0vpWdFa4EogqiCx9lcEg5m8lD9_bfbLjRM-bxg5TC-0DgN2fgDudqqenfq8Th_dwlmY-vNB0hnAO-DC6X0fe7g==\" rel=\"nofollow noopener noreferrer\" target=\"_blank\">LinkedIn<\/a>), including but not limited to investor presentations and investor fact sheets,\u00a0U.S. Securities and Exchange Commission\u00a0filings, press releases, public conference calls and webcasts. The information that Orchard posts on these channels and websites could be deemed to be material information. As a result, Orchard encourages investors, the media, and others interested in Orchard to review the information that is posted on these channels, including the investor relations website, on a regular basis. This list of channels may be updated from time to time on Orchard\u2019s investor relations website and may include additional social media channels. The contents of Orchard\u2019s website or these channels, or any other website that may be accessed from its website or these channels, shall not be deemed incorporated by reference in any filing under the Securities Act of 1933.<\/p>\n<p>\n        <strong>Contacts<\/strong>\n      <\/p>\n<p>\n        <strong>Investors<\/strong>\n      <\/p>\n<p>Renee Leck<br \/>Director, Investor Relations<br \/>+1 862-242-0764<br \/>Renee.Leck@orchard-tx.com<\/p>\n<\/p>\n<p>      <img loading=\"lazy\" decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODA5MDk3MSMzODQwNjI1IzIxMjQwNTk=\" width=\"1\" height=\"1\" \/><br \/>\n      <br \/>\n      <img loading=\"lazy\" decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/ml.globenewswire.com\/release\/track\/95003d61-bd8d-4f48-8454-2b69db2689f6\" width=\"1\" height=\"1\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>BOSTON and LONDON, Nov. 24, 2020 (GLOBE NEWSWIRE) &#8212; Orchard Therapeutics (Nasdaq: ORTX), a global gene therapy leader, today announced that its chief executive officer, Bobby Gaspar, M.D., Ph.D. will participate in a pre-recorded fireside chat as part of the Piper Sandler 32nd Annual Virtual Healthcare Conference. Management will also be available for one-on-one meetings on Tuesday, December 1, 2020. The fireside chat is available for on-demand viewing under &#8220;Events&#8221; in the Investors &amp; Media section of the company&#8217;s website at www.orchard-tx.com and will remain available for approximately 90 days. About Orchard Orchard Therapeutics is a global gene therapy leader dedicated to transforming the lives of people affected by rare diseases through the development of innovative, potentially curative gene therapies. &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/orchard-therapeutics-to-present-at-piper-sandler-32nd-annual-virtual-healthcare-conference\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Orchard Therapeutics to Present at Piper Sandler 32nd Annual Virtual Healthcare Conference&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-387424","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.8 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Orchard Therapeutics to Present at Piper Sandler 32nd Annual Virtual Healthcare Conference - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/orchard-therapeutics-to-present-at-piper-sandler-32nd-annual-virtual-healthcare-conference\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Orchard Therapeutics to Present at Piper Sandler 32nd Annual Virtual Healthcare Conference - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"BOSTON and LONDON, Nov. 24, 2020 (GLOBE NEWSWIRE) &#8212; Orchard Therapeutics (Nasdaq: ORTX), a global gene therapy leader, today announced that its chief executive officer, Bobby Gaspar, M.D., Ph.D. will participate in a pre-recorded fireside chat as part of the Piper Sandler 32nd Annual Virtual Healthcare Conference. Management will also be available for one-on-one meetings on Tuesday, December 1, 2020. The fireside chat is available for on-demand viewing under &#8220;Events&#8221; in the Investors &amp; Media section of the company&#8217;s website at www.orchard-tx.com and will remain available for approximately 90 days. About Orchard Orchard Therapeutics is a global gene therapy leader dedicated to transforming the lives of people affected by rare diseases through the development of innovative, potentially curative gene therapies. &hellip; Continue reading &quot;Orchard Therapeutics to Present at Piper Sandler 32nd Annual Virtual Healthcare Conference&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/orchard-therapeutics-to-present-at-piper-sandler-32nd-annual-virtual-healthcare-conference\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2020-11-24T12:03:28+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODA5MDk3MSMzODQwNjI1IzIxMjQwNTk=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/orchard-therapeutics-to-present-at-piper-sandler-32nd-annual-virtual-healthcare-conference\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/orchard-therapeutics-to-present-at-piper-sandler-32nd-annual-virtual-healthcare-conference\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Orchard Therapeutics to Present at Piper Sandler 32nd Annual Virtual Healthcare Conference\",\"datePublished\":\"2020-11-24T12:03:28+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/orchard-therapeutics-to-present-at-piper-sandler-32nd-annual-virtual-healthcare-conference\\\/\"},\"wordCount\":450,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/orchard-therapeutics-to-present-at-piper-sandler-32nd-annual-virtual-healthcare-conference\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODA5MDk3MSMzODQwNjI1IzIxMjQwNTk=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/orchard-therapeutics-to-present-at-piper-sandler-32nd-annual-virtual-healthcare-conference\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/orchard-therapeutics-to-present-at-piper-sandler-32nd-annual-virtual-healthcare-conference\\\/\",\"name\":\"Orchard Therapeutics to Present at Piper Sandler 32nd Annual Virtual Healthcare Conference - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/orchard-therapeutics-to-present-at-piper-sandler-32nd-annual-virtual-healthcare-conference\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/orchard-therapeutics-to-present-at-piper-sandler-32nd-annual-virtual-healthcare-conference\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODA5MDk3MSMzODQwNjI1IzIxMjQwNTk=\",\"datePublished\":\"2020-11-24T12:03:28+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/orchard-therapeutics-to-present-at-piper-sandler-32nd-annual-virtual-healthcare-conference\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/orchard-therapeutics-to-present-at-piper-sandler-32nd-annual-virtual-healthcare-conference\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/orchard-therapeutics-to-present-at-piper-sandler-32nd-annual-virtual-healthcare-conference\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODA5MDk3MSMzODQwNjI1IzIxMjQwNTk=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODA5MDk3MSMzODQwNjI1IzIxMjQwNTk=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/orchard-therapeutics-to-present-at-piper-sandler-32nd-annual-virtual-healthcare-conference\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Orchard Therapeutics to Present at Piper Sandler 32nd Annual Virtual Healthcare Conference\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Orchard Therapeutics to Present at Piper Sandler 32nd Annual Virtual Healthcare Conference - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/orchard-therapeutics-to-present-at-piper-sandler-32nd-annual-virtual-healthcare-conference\/","og_locale":"en_US","og_type":"article","og_title":"Orchard Therapeutics to Present at Piper Sandler 32nd Annual Virtual Healthcare Conference - Market Newsdesk","og_description":"BOSTON and LONDON, Nov. 24, 2020 (GLOBE NEWSWIRE) &#8212; Orchard Therapeutics (Nasdaq: ORTX), a global gene therapy leader, today announced that its chief executive officer, Bobby Gaspar, M.D., Ph.D. will participate in a pre-recorded fireside chat as part of the Piper Sandler 32nd Annual Virtual Healthcare Conference. Management will also be available for one-on-one meetings on Tuesday, December 1, 2020. The fireside chat is available for on-demand viewing under &#8220;Events&#8221; in the Investors &amp; Media section of the company&#8217;s website at www.orchard-tx.com and will remain available for approximately 90 days. About Orchard Orchard Therapeutics is a global gene therapy leader dedicated to transforming the lives of people affected by rare diseases through the development of innovative, potentially curative gene therapies. &hellip; Continue reading \"Orchard Therapeutics to Present at Piper Sandler 32nd Annual Virtual Healthcare Conference\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/orchard-therapeutics-to-present-at-piper-sandler-32nd-annual-virtual-healthcare-conference\/","og_site_name":"Market Newsdesk","article_published_time":"2020-11-24T12:03:28+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODA5MDk3MSMzODQwNjI1IzIxMjQwNTk=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/orchard-therapeutics-to-present-at-piper-sandler-32nd-annual-virtual-healthcare-conference\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/orchard-therapeutics-to-present-at-piper-sandler-32nd-annual-virtual-healthcare-conference\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Orchard Therapeutics to Present at Piper Sandler 32nd Annual Virtual Healthcare Conference","datePublished":"2020-11-24T12:03:28+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/orchard-therapeutics-to-present-at-piper-sandler-32nd-annual-virtual-healthcare-conference\/"},"wordCount":450,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/orchard-therapeutics-to-present-at-piper-sandler-32nd-annual-virtual-healthcare-conference\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODA5MDk3MSMzODQwNjI1IzIxMjQwNTk=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/orchard-therapeutics-to-present-at-piper-sandler-32nd-annual-virtual-healthcare-conference\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/orchard-therapeutics-to-present-at-piper-sandler-32nd-annual-virtual-healthcare-conference\/","name":"Orchard Therapeutics to Present at Piper Sandler 32nd Annual Virtual Healthcare Conference - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/orchard-therapeutics-to-present-at-piper-sandler-32nd-annual-virtual-healthcare-conference\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/orchard-therapeutics-to-present-at-piper-sandler-32nd-annual-virtual-healthcare-conference\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODA5MDk3MSMzODQwNjI1IzIxMjQwNTk=","datePublished":"2020-11-24T12:03:28+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/orchard-therapeutics-to-present-at-piper-sandler-32nd-annual-virtual-healthcare-conference\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/orchard-therapeutics-to-present-at-piper-sandler-32nd-annual-virtual-healthcare-conference\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/orchard-therapeutics-to-present-at-piper-sandler-32nd-annual-virtual-healthcare-conference\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODA5MDk3MSMzODQwNjI1IzIxMjQwNTk=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODA5MDk3MSMzODQwNjI1IzIxMjQwNTk="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/orchard-therapeutics-to-present-at-piper-sandler-32nd-annual-virtual-healthcare-conference\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Orchard Therapeutics to Present at Piper Sandler 32nd Annual Virtual Healthcare Conference"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/387424","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=387424"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/387424\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=387424"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=387424"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=387424"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}